Inactive

The purpose of Amendment 2 (two) is to post responses to submitted questions via Attachment 03: Amend 2_RFQ_75N95022Q00249_QandA. The purpose of this Amendment is to: 1) post responses to submitted qu... The purpose of Amendment 2 (two) is to post responses to submitted questions via Attachment 03: Amend 2_RFQ_75N95022Q00249_QandA. The purpose of this Amendment is to: 1) post responses to submitted questions via Attachment 01: RFQ_75N95022Q00249_QandA; and 2) revise the Price Template see Attachment 02 REVISED Price Template. The NINDS is seeking part-time Drug Metabolism and Pharmacokinetics (DMPK) Consultants to provide technical recommendations to support the translational development of neurological and pain therapeutics for NIH’s Blueprint Neurotherapeutics Network (BPN) drug discovery and development programs. Several such programs are being launched or expanded to provide support for investigators developing medicinal interventions for neurological disorders. The DMPK Consultants will support BPN’s Small Molecule and Helping to End Long-term® Addiction (HEAL) Pain Therapeutics Development Program (PTDP) by providing consulting services for candidate small molecule or biological therapeutics development.